Olanzapine Impurity B (EP)

GA01138

Olanzapine (originally branded Zyprexa) is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. It is structurally similar to clozapine and quetiapine. It is a dopamine antagonist and is classified as a thienobenzodiazepine.

We have successfully synthesized impurities of the Olanzapine. This will be of interest to pharmaceutical companies and analytical labs.